EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. (ECILC.IS)
TRY 45.72
(1.02%)
TRY 45.72
(1.02%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 4.4 Billion TRY | -41.55% |
| 2022 | 4.78 Billion TRY | 302.83% |
| 2021 | 1.53 Billion TRY | 127.32% |
| 2020 | 423.68 Million TRY | 58.07% |
| 2019 | 308.42 Million TRY | -16.1% |
| 2018 | 313.51 Million TRY | 143.46% |
| 2017 | 302.99 Million TRY | -47.79% |
| 2016 | 250.09 Million TRY | 86.23% |
| 2015 | 114.14 Million TRY | 1574.02% |
| 2014 | 4.66 Million TRY | -107.51% |
| 2013 | 157.21 Million TRY | 24.32% |
| 2012 | 76.12 Million TRY | 203.7% |
| 2011 | 160.33 Million TRY | -55.23% |
| 2010 | 70.05 Million TRY | 96.07% |
| 2009 | 35.72 Million TRY | -90.6% |
| 2008 | 14.8 Million TRY | 866.53% |
| 2007 | 535.45 Million TRY | -61.25% |
| 2006 | 101.51 Million TRY | 78.32% |
| 2005 | 56.93 Million TRY | -61.8% |
| 2004 | 149.03 Million TRY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 1.03 Billion TRY | -73.5% |
| 2024 Q2 | -121.3 Million TRY | -112.21% |
| 2024 Q3 | 906.96 Million TRY | 1116.53% |
| 2023 FY | - TRY | -41.55% |
| 2023 Q4 | 1.01 Billion TRY | 207.72% |
| 2023 Q3 | 330.38 Million TRY | -69.37% |
| 2023 Q1 | 444.98 Million TRY | -85.41% |
| 2023 Q2 | 1.07 Billion TRY | 142.39% |
| 2022 FY | - TRY | 302.83% |
| 2022 Q4 | 3.05 Billion TRY | 1103.51% |
| 2022 Q3 | 253.42 Million TRY | 19.83% |
| 2022 Q1 | 252.84 Million TRY | -52.28% |
| 2022 Q2 | 211.49 Million TRY | -16.35% |
| 2021 Q3 | 82.41 Million TRY | -43.54% |
| 2021 FY | - TRY | 127.32% |
| 2021 Q2 | 145.97 Million TRY | -17.56% |
| 2021 Q1 | 177.05 Million TRY | 3830.17% |
| 2021 Q4 | 529.85 Million TRY | 542.93% |
| 2020 Q3 | 181.21 Million TRY | 50.11% |
| 2020 Q1 | 105.01 Million TRY | 20.17% |
| 2020 FY | - TRY | 58.07% |
| 2020 Q2 | 120.72 Million TRY | 14.96% |
| 2020 Q4 | 4.5 Million TRY | -97.51% |
| 2019 Q3 | 37.47 Million TRY | -71.71% |
| 2019 Q4 | 87.38 Million TRY | 133.21% |
| 2019 FY | - TRY | -16.1% |
| 2019 Q1 | 36.69 Million TRY | 67.01% |
| 2019 Q2 | 132.44 Million TRY | 260.94% |
| 2018 Q1 | 69.6 Million TRY | 399.47% |
| 2018 Q2 | 140.39 Million TRY | 101.7% |
| 2018 Q4 | 21.97 Million TRY | -85.44% |
| 2018 Q3 | 150.84 Million TRY | 7.45% |
| 2018 FY | - TRY | 143.46% |
| 2017 Q1 | 57.59 Million TRY | 15.28% |
| 2017 Q4 | -23.24 Million TRY | -240.38% |
| 2017 Q3 | 16.55 Million TRY | -79.13% |
| 2017 FY | - TRY | -47.79% |
| 2017 Q2 | 79.32 Million TRY | 37.74% |
| 2016 Q3 | 49 Million TRY | -50.04% |
| 2016 Q4 | 49.95 Million TRY | 1.93% |
| 2016 Q1 | 47.03 Million TRY | 211.11% |
| 2016 FY | - TRY | 86.23% |
| 2016 Q2 | 98.09 Million TRY | 108.56% |
| 2015 Q3 | 87.51 Million TRY | 159.79% |
| 2015 FY | - TRY | 1574.02% |
| 2015 Q4 | -42.33 Million TRY | -148.37% |
| 2015 Q2 | 33.68 Million TRY | -35.48% |
| 2015 Q1 | 52.2 Million TRY | 303.87% |
| 2014 Q2 | -4.32 Million TRY | -117.24% |
| 2014 Q4 | -25.6 Million TRY | -345.11% |
| 2014 Q3 | -5.75 Million TRY | -32.89% |
| 2014 FY | - TRY | -107.51% |
| 2014 Q1 | 25.11 Million TRY | 32.92% |
| 2013 Q3 | 49.91 Million TRY | 27.4% |
| 2013 Q4 | 18.89 Million TRY | -62.15% |
| 2013 FY | - TRY | 24.32% |
| 2013 Q1 | 8.94 Million TRY | -85.71% |
| 2013 Q2 | 39.18 Million TRY | 337.98% |
| 2012 Q3 | 17.29 Million TRY | 265.68% |
| 2012 FY | - TRY | 203.7% |
| 2012 Q2 | -10.44 Million TRY | -249.57% |
| 2012 Q1 | 6.98 Million TRY | 246.73% |
| 2012 Q4 | 62.6 Million TRY | 261.95% |
| 2011 Q4 | -4.75 Million TRY | -131.94% |
| 2011 Q3 | 14.89 Million TRY | 113.12% |
| 2011 Q2 | 6.98 Million TRY | -50.92% |
| 2011 Q1 | 14.23 Million TRY | 54.58% |
| 2011 FY | - TRY | -55.23% |
| 2010 Q1 | 26.76 Million TRY | 0.0% |
| 2010 Q4 | 9.21 Million TRY | -26.24% |
| 2010 FY | - TRY | 96.07% |
| 2010 Q3 | 12.48 Million TRY | -42.18% |
| 2010 Q2 | 21.59 Million TRY | -19.31% |
| 2009 FY | - TRY | -90.6% |
| 2008 FY | - TRY | 866.53% |
| 2007 FY | - TRY | -61.25% |
| 2006 FY | - TRY | 78.32% |
| 2005 FY | - TRY | -61.8% |
| 2004 FY | - TRY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|